Related Experiment Videos
Blind and bronchoscopic sampling methods in suspected ventilator-associated pneumonia. A multicentre prospective
Hervé Mentec1, Laetitia May-Michelangeli, Antoine Rabbat
1Service de Réanimation Polyvalente, Hôpital Victor Dupouy, 69 rue du Lieutenant-Colonel Prudhon, 95107 Argenteuil, France. hmentec@fc.horus-medical.fr
Intensive Care Medicine
|April 21, 2004
Summary
Blind protected telescoping catheter (PTC) sampling is a viable alternative to bronchoscopic bronchoalveolar lavage for diagnosing ventilator-associated pneumonia (VAP). This method is effective when samples contain visible secretions, offering a less invasive diagnostic approach.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Pulmonary Medicine
Background:
- Ventilator-associated pneumonia (VAP) is a significant complication in mechanically ventilated patients.
- Accurate diagnosis of VAP is crucial for appropriate antibiotic selection and improved patient outcomes.
Purpose of the Study:
- To compare the diagnostic accuracy of four distinct sampling methods for VAP.
- Evaluate blind tracheal aspirate (TA), blind protected telescoping catheter (PTC), bronchoscopic PTC, and bronchoscopic bronchoalveolar lavage (BAL).
Main Methods:
- A prospective, multicenter study involving 63 patients on mechanical ventilation for over 48 hours.
- All four sampling methods were performed on each patient.
- Direct examination and quantitative cultures were analyzed for diagnostic yield.
Main Results:
- Direct examination of PTC samples (blind or bronchoscopic) showed comparable diagnostic performance to bronchoscopic BAL.
- Receiver operating characteristic (ROC) curve analysis indicated that blind TA and PTC methods had smaller areas under the curve than bronchoscopic BAL.
- When visible secretions were present in PTC samples, their diagnostic accuracy approached that of bronchoscopic BAL.
Conclusions:
- Blind PTC sampling is a practical alternative to bronchoscopic methods for VAP diagnosis.
- The utility of blind PTC is contingent on obtaining samples with visible secretions.
- This finding supports less invasive diagnostic strategies in VAP management.